Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

SWTX holding history

SpringWorks Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SWTX overviewAll 13F holders of SWTXFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of SWTX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−201,100−100.0%Sold outHolders
Q2 2025201,100$9.45M<0.1%−1,462,383−87.9%ReducedHolders
Q1 20251,663,483$73.4M0.1%+1,275,750+329.0%AddedHolders
Q4 2024387,733$14.0M<0.1%−336,949−46.5%ReducedHolders
Q3 2024724,682$23.2M<0.1%−34,030−4.5%ReducedHolders
Q2 2024758,712$28.6M<0.1%+109,865+16.9%AddedHolders
Q1 2024648,847$31.9M<0.1%+518,535+397.9%AddedHolders
Q4 2023130,312$4.76M<0.1%+24,576+23.2%AddedHolders
Q3 2023105,736$2.44M<0.1%−64,311−37.8%ReducedHolders
Q2 2023170,047$4.46M<0.1%−136,498−44.5%ReducedHolders
Q1 2023306,545$7.89M<0.1%+120,625+64.9%AddedHolders
Q4 2022185,920$4.84M<0.1%+40,310+27.7%AddedHolders
Q3 2022145,610$4.15M<0.1%−99,853−40.7%ReducedHolders
Q2 2022245,463$6.04M<0.1%+245,463NewHolders
Q1 20220$00.0%−55,704−100.0%Sold outHolders
Q4 202155,704$3.45M<0.1%−44,753−44.5%ReducedHolders
Q3 2021100,457$6.37M<0.1%−25,422−20.2%ReducedHolders
Q2 2021125,879$10.4M<0.1%−24,362−16.2%ReducedHolders
Q1 2021150,241$11.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.